Technical analysis of Plus Therapeutics, Inc. (PSTV): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Plus Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, dedicated to the development, manufacturing, and market introduction of therapeutic solutions for cancer patients and individuals with other serious illnesses.
Price Performance
| 1 month | +0.00% |
| 3 months | -7.86% |
| Year-to-date | -69.79% |
| 1 year | -62.86% |
| 3 years | -88.27% |
| 5 years | -99.48% |
52-Week Range
| 52-week High | $23.43 |
| 52-week Low | $2.90 |
| Avg Volume (90d) | 270K |
Technical Indicators
| SMA 50 | $4.66 |
| SMA 200 | $8.43 |
| Beta | 1.02 |
| 30-day Volatility (annualised) | 54.6% |
| Price vs SMA 50 | -16.9% |
| Price vs SMA 200 | -54.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $13.58 | |
| 2025-11 | $15.25 | +12.3% |
| 2025-12 | $12.81 | -16.0% |
| 2026-01 | $5.70 | -55.5% |
| 2026-02 | $7.57 | +32.8% |
| 2026-03 | $4.06 | -46.4% |
| 2026-04 | $6.14 | +51.2% |
| 2026-05 | $5.82 | -5.2% |
| 2026-06 | $4.37 | -24.9% |
| 2026-07 | $3.87 | -11.4% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $0.10 | $672M |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | $898M |
| 2026-09-14 | $0.03 | $3M |
Price
| Price | $3.87 |
| Market Cap | $9M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 4.80 |
| EV / EBITDA | -1.74 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 1.37 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -44.86 |